FTRE
NASDAQ · Life Sciences Tools & Services
Fortrea Holdings Inc
$18.43
+0.74 (+4.18%)
Financial Highlights (FY 2026)
Revenue
2.83B
Net Income
-1,023,743,532
Gross Margin
18.5%
Profit Margin
-36.2%
Rev Growth
-4.2%
D/E Ratio
1.87
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 18.5% | 18.5% | 33.3% | 33.3% |
| Operating Margin | -32.0% | -28.8% | 4.2% | 4.3% |
| Profit Margin | -36.2% | -34.4% | 3.9% | 4.5% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 2.83B | 2.95B | 1.34B | 1.39B |
| Gross Profit | 523.01M | 545.88M | 445.86M | 460.95M |
| Operating Income | -905,793,834 | -850,865,724 | 56.52M | 59.15M |
| Net Income | -1,023,743,532 | -961,662,852 | 52.33M | 61.93M |
| Gross Margin | 18.5% | 18.5% | 33.3% | 33.3% |
| Operating Margin | -32.0% | -28.8% | 4.2% | 4.3% |
| Profit Margin | -36.2% | -34.4% | 3.9% | 4.5% |
| Rev Growth | -4.2% | -4.2% | +7.6% | +19.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 547.90M | 547.90M | 574.49M | 632.75M |
| Total Equity | 293.26M | 293.26M | 884.45M | 884.57M |
| D/E Ratio | 1.87 | 1.87 | 0.65 | 0.72 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -824,847,439 | -817,873,987 | 75.93M | 85.51M |
| Free Cash Flow | — | — | 62.53M | 81.90M |